Works matching IS 0008543X AND DT 2023 AND VI 129 AND IP 10


Results: 22
    1
    2
    5

    Reply to "Hepatocellular carcinoma in thalassemia and other hemoglobinopathies".

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 10, p. 1616, doi. 10.1002/cncr.34736
    By:
    • Origa, Raffaella;
    • Gianesin, Barbara;
    • Longo, Filomena;
    • Di Maggio, Rosario;
    • Cassinerio, Elena;
    • Gamberini, Maria Rita;
    • Pinto, Valeria Maria;
    • Casale, Maddalena;
    • La Nasa, Giorgio;
    • Caocci, Giovanni;
    • Piroddi, Antonio;
    • Piolatto, Andrea;
    • Di Mauro, Alessandra;
    • Romano, Claudia;
    • Gigante, Antonia;
    • Barella, Susanna;
    • Maggio, Aurelio;
    • Graziadei, Giovanna;
    • Perrotta, Silverio;
    • Forni, Gian Luca
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14

    A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 10, p. 1537, doi. 10.1002/cncr.34709
    By:
    • Janku, Filip;
    • Javle, Milind M.;
    • Sen, Shiraj;
    • Pant, Shubham;
    • Bramwell, Lindsay G.;
    • Subbiah, Vivek;
    • Way, Tracey;
    • Wages, David S.;
    • Wheeler, Catherine A.;
    • Suzuki, Takeaki;
    • Saeki, Kazunori;
    • Subach, Ruth Ann;
    • Madden, Timothy;
    • Maier, Gary;
    • Johansen, Mary J.;
    • Cheung, Kin;
    • Falchook, Gerald S.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    Issue Information.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 10, p. 1457, doi. 10.1002/cncr.33711
    Publication type:
    Article
    22